Compare IART & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IART | INMD |
|---|---|---|
| Founded | 1989 | 2008 |
| Country | United States | Israel |
| Employees | 4427 | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 842.0M |
| IPO Year | 1996 | 2018 |
| Metric | IART | INMD |
|---|---|---|
| Price | $15.11 | $13.82 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 7 | 5 |
| Target Price | $14.33 | ★ $17.33 |
| AVG Volume (30 Days) | ★ 1.1M | 768.1K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.39 | $1.74 |
| Revenue Next Year | $3.40 | $3.26 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.70 | $12.72 |
| 52 Week High | $16.42 | $16.74 |
| Indicator | IART | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 70.06 | 44.92 |
| Support Level | $12.64 | $13.27 |
| Resistance Level | $16.35 | $13.87 |
| Average True Range (ATR) | 0.91 | 0.32 |
| MACD | 0.11 | -0.03 |
| Stochastic Oscillator | 90.11 | 47.03 |
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.